According to Mirati Therapeutics's latest financial reports the company's current earnings (TTM) are -C$1.04 B. In 2022 the company made an earning of -C$1.04 B a decrease over its 2021 earnings that were of -C$0.78 B.The earnings displayed on this page is the company's Pretax Income.